Silverman Joshua 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Silverman Joshua（CIK 1524858）在 5 家公司共报告 20 笔 SEC Form 4 内部人交易（最近一笔 2026-10-02）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-10-02 | Q/C TECHNOLOGIES, INC. (QCLS) | Executive Chairman | 买入 | 16,620 | $0 |
| 2026-10-02 | Q/C TECHNOLOGIES, INC. (QCLS) | Executive Chairman | 买入 | 16,806 | $0 |
| 2026-10-02 | Q/C TECHNOLOGIES, INC. (QCLS) | Executive Chairman | 买入 | 77,390 | $0 |
| 2026-08-14 | Fabric.AI, Inc. (FABC) | Chief Executive Officer | 买入 | 358,565 | $0 |
| 2026-08-14 | Fabric.AI, Inc. (FABC) | Chief Executive Officer | 卖出 | 44,820 | $165,834 |
| 2026-08-14 | Fabric.AI, Inc. (FABC) | Chief Executive Officer | 卖出 | 44,820 | $165,386 |
| 2026-06-05 | Petros Pharmaceuticals, Inc. (PTPI) | 董事 | 买入 | 4.4M | $0 |
| 2026-04-15 | Q/C TECHNOLOGIES, INC. (QCLS) | Executive Chairman | 买入 | 162,162 | $0 |
| 2026-01-07 | PharmaCyte Biotech, Inc. (PMCB) | CEO and President | 买入 | 30,000 | $23,400 |
| 2026-01-07 | PharmaCyte Biotech, Inc. (PMCB) | CEO and President | 买入 | 30,000 | $23,700 |
| 2026-01-07 | PharmaCyte Biotech, Inc. (PMCB) | CEO and President | 买入 | 40,000 | $33,200 |
| 2026-01-02 | Petros Pharmaceuticals, Inc. (PTPI) | 董事 | 买入 | 4.4M | $0 |
| 2025-12-12 | PharmaCyte Biotech, Inc. (PMCB) | CEO and President | 买入 | 575,000 | $0 |
| 2025-12-12 | PharmaCyte Biotech, Inc. (PMCB) | CEO and President | 卖出 | 258,750 | $263,925 |
| 2025-11-14 | Q/C TECHNOLOGIES, INC. (QCLS) | Executive Chairman | 买入 | 91,356 | $0 |
| 2025-10-17 | TAO Synergies Inc. (TAOX) | Executive Chairman | 买入 | 100,000 | $0 |
| 2025-10-17 | TAO Synergies Inc. (TAOX) | Executive Chairman | 卖出 | 40,000 | $289,200 |
| 2025-10-06 | Q/C TECHNOLOGIES, INC. (QCLS) | Executive Chairman | 买入 | 8,644 | $0 |
| 2025-07-02 | TAO Synergies Inc. (TAOX) | Executive Chairman | 买入 | 41,919 | $0 |
| 2025-07-02 | TAO Synergies Inc. (TAOX) | Executive Chairman | 卖出 | 16,768 | $131,629 |
来源：SEC Form 4 申报文件 · 截至 2026-10-02